Erythropoietin effects on dendritic cells: potential mediators in its function as an immunomodulator?
D018122:B7-1 Antigen / Q000276:immunology; D051940:B7-2 Antigen / Q000276:immunology; D003713:Dendritic Cells / Q000166:cytology / Q000276:immunology*; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000276:immunology / Q000494:pharmacology*; D005786:Gene Expression Regulation / Q000187:drug effects* / Q000276:immunology; D006684:HLA-DR Antigens / Q000276:immunology; D006397:Hematinics / Q000276:immunology / Q000494:pharmacology; D006801:Humans; D007155:Immunologic Factors / Q000276:immunology / Q000494:pharmacology*; D018664:Interleukin-12 / Q000276:immunology; D009000:Monocytes / Q000166:cytology / Q000276:immunology*; D017467:Receptors, Erythropoietin / Q000819:agonists / Q000276:immunology*; D011994:Recombinant Proteins; D013601:T-Lymphocytes / Q000166:cytology / Q000276:immunology
D018122:B7-1 Antigen; D051940:B7-2 Antigen; C497964:CD86 protein, human; D006684:HLA-DR Antigens; D006397:Hematinics; D007155:Immunologic Factors; D017467:Receptors, Erythropoietin; D011994:Recombinant Proteins; D004921:Erythropoietin; D018664:Interleukin-12; D000068817:Epoetin Alfa